Moores UC San Diego Cancer Center

3855 Health Sciences Drive
San Diego, California 92093

We've found

1 trials

at this facility

A Study of Itacitinib (INCB039110) in Combination With Ibrutinib in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Status: Enrolling, Phase I, II
Updated: 12/31/1969

from

San Diego, CA

Use our guide to learn which trials are right for you!